Christiane Amendt

Christiane Amendt

Company: Merck KGaA

Job title: Global Head - Translational In Vivo Pharmacology, Translational Innovation Platform Oncology

Seminars:

Panel Discussion: Limitations of Humanised & PDX Models 2:00 pm

How can we push these borders to include more supporting immune cells, dendritic cells, NK-cells? Increasing longevity; CD34 humanised hyper immune-deficient mice can increase available study lengths but also increase the cost. Is there a middle ground? Gaining data on persistence of cellular therapies without requiring additional miceRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.